AI models for legal work
Legal AI models should be compared as a work stack: frontier model, legal retrieval, OCR, embeddings, reranking, deployment controls, source permissions and lawyer review.
MODELSLegal servicesGLOBAL
2026-06-19
region
GLOBAL
File processing providers for legal AI
The parser decides what the model is allowed to know. Compare OCR, extraction, signatures, redlines, VDR ingestion, eDiscovery exceptions, controls, pricing, and benchmarks by whether they preserve evidence a lawyer can verify.
AGENTSLegal servicesGLOBAL
2026-06-19
File processing providers for financial AI
Compares financial AI file-processing providers by file class, source linkage, exception handling, system-of-record fit, controls, pricing and accepted financial record quality.
AGENTSFinancial servicesGLOBAL
2026-06-19
AI models for financial services
Financial AI models should be compared by accepted output: source authority, model-risk evidence, deployment controls, benchmark caveats, workflow permission and full cost.
MODELSFinancial servicesGLOBAL
2026-06-19
AI agents for software engineering
Software-engineering AI agents should be bought against accepted delivery: PR acceptance, CI authority, review capacity, rollback ownership and usage cost after failed attempts.
AGENTSTechnologyGLOBAL
2026-06-17
AI agents for architecture and AEC
Architecture agents become useful when the project record they touch is explicit: site assumptions, BIM writes, code sources, reviewer gates, handoff evidence and rework economics.
AGENTSArchitecture, engineering and constructionGLOBAL
2026-06-17
AI agents for urban planning
Planning agents create value first where fragmented policy, parcel, comment, plan-sheet and GIS evidence becomes a reviewable packet that reduces backlog without delegating judgement.
AGENTSPublic sectorGLOBAL
2026-06-17
AI agents for financial services
Financial AI agents should be approved by write-path consequence: posting, payment, file, customer action, rollback, system-of-record context, audit evidence and control ownership.
AGENTSFinancial servicesGLOBAL
2026-06-17
AI agents for private equity diligence and portfolio operations
Private-equity agents become usable when VDR chain of custody, IC source trace, workbook diffs, KPI lineage and LP-report release controls survive review.
AGENTSFinancial servicesGLOBAL
2026-06-17
AI for customer-service workflows
Customer-service AI is splitting by control rights. Helpdesk and CCaaS incumbents keep gravity when they own records and channels; specialists win when a narrow workflow needs faster action, better voice execution, or auditable outcome economics.
AGENTSCustomer experienceGLOBAL
2026-06-16
AI customer-service workflow approval gates
Customer-service AI is moving from answer bots to workflow agents. The useful approval test asks whether the agent has approved action rights, can prove accepted resolution after repeat contacts and handoffs, and has a tested recovery path when the service path fails.
AGENTSCustomer experienceGLOBAL
2026-06-16
AI customer-service pricing and ticket economics
Compare support automation by accepted resolution: repeat contacts, handoffs, retained human work and invoice definitions decide the cost behind each outcome, tier, ticket, session, credit or platform charge.
AGENTSCustomer experienceGLOBAL
2026-06-16
AI models for banking, capital markets, and insurance
Compares AI models across banking, capital markets and insurance by source authority, customer impact, market proximity, model risk, retrieval quality, benchmark evidence, deployment channel, data rights and cost per accepted financial output.
MODELSFinancial servicesGLOBAL
2026-06-16
AI FinOps and inference cost governance
As inference bills scale, spend approval depends on one denominator joining invoices, traces, reviewer work and accepted outputs before more AI spend is approved.
INFRATechnologyGLOBAL
2026-06-16
AI agent security, identity and permissions
Agent risk now sits in identity and delegated authority. Buyers should approve the credentialed route, not the agent brand, before write access, browsing, code execution or MCP tools move into production.
AGENTSTechnologyGLOBAL
2026-06-13
Deployment options for open-weight LLM models
Open-weight LLM deployment is an infrastructure decision across licence, data boundary, serving stack, utilisation, latency, retrieval, controls, recovery and accepted-output cost.
INFRACross-industryGLOBAL
2026-06-08
Embodied AI infrastructure
Embodied AI infrastructure is not the robot brain; it is the evidence system that turns simulation, data, VLA policies and fleet logs into approvable physical work.
INFRACross-industryGLOBAL
2026-06-05
AI infrastructure for the robot software stack
Robot software value is shifting from isolated autonomy demos to the production record that connects bodies, simulators, runtime telemetry, safety cases, update paths and site-specific deployment evidence.
INFRACross-industryGLOBAL
2026-06-05
AI infrastructure for robot operating systems after ROS
Commercial robot platforms can standardize deployment, telemetry and evidence above ROS 2, but production value depends on accepted physical output, integration labour, replayable incidents, OT security and body-specific approval.
INFRACross-industryGLOBAL
2026-06-05
AI agents for hospitals and health systems
Hospital AI agents should earn authority from EHR telemetry: source capture, note placement, clinician edits, PHI boundaries, exception queues and downstream coding, inbox or care-coordination rework.
AGENTSHealthcare deliveryGLOBAL
2026-06-02
AI models for clinical diagnostics and imaging
Diagnostics and imaging models should be evaluated by accountable follow-up: authorised use, local case mix, equipment, reader behaviour, alert burden, monitoring, update rights and follow-up capacity.
MODELSHealthcare deliveryGLOBAL
2026-06-02
AI infrastructure for hospitals and health systems
Hospital AI infrastructure should control patient context: identity-bound PHI access, FHIR and EHR normalization, retrieval provenance, model-channel policy, audit evidence, downtime recovery and write-back.
INFRAHealthcare deliveryGLOBAL
2026-06-02
Vertical AI agents for service operations
Vertical service agents are strongest when they package a repeatable unit of work, write it back to the right system, recover from exceptions, and let finance measure the finished job rather than the conversation.
AGENTSCustomer experienceGLOBAL
2026-06-01
Developer voice infrastructure for customer-service agents
Developer voice infrastructure has made the voice-agent prototype cheap: telephony, streaming speech, interruption handling and model routing now arrive as APIs. The production bottleneck is still the buyer's contact-centre operating layer: latency budgets, consent, tool permissions, logs, evaluation, failover and CRM writes.
INFRACustomer experienceGLOBAL
2026-06-01
AI sandboxes for agent execution
AI sandboxes are becoming the boundary where agents move from chat to action. Buyers should choose the approved execution route for code, browser, tools, state, credentials, recovery and evidence across model providers, hyperscalers, hosted sandbox platforms, browser routes and self-hosted runtimes.
INFRATechnologyGLOBAL
2026-06-01
AI infrastructure for life sciences data and labs
Life-sciences AI infrastructure depends on which notebook methods, sample records, instrument files, omics runs and automation logs can cross into AI use while preserving source ownership, permissions, reviewer action and validation evidence.
INFRALife sciencesGLOBAL
2026-06-01
AI agents for revenue cycle and prior authorization
Revenue-cycle agents should close a payer-specific yield loop: policy discovery, chart evidence, submission, status, denial reasons, appeals and cash outcome telemetry feeding the next authorization request.
AGENTSHealthcare deliveryGLOBAL
2026-06-01
AI agents for pharmacy, PBMs and medication workflows
Pharmacy and PBM AI should prove a drug-class access ledger: benefit rule, formulary evidence, prior-auth result, channel, patient cost, paid fill, continuation and safety escalation.
AGENTSPharmacy and benefitsGLOBAL
2026-06-01
AI models for pharma and biotech R&D
Pharma and biotech R&D AI should be evaluated as an experiment-capacity allocator: the model earns budget when it changes which targets, molecules, assays, biomarkers or IND/CTA-supporting analyses consume scarce validation slots.
MODELSLife sciencesGLOBAL
2026-06-01
AI agents for clinical trials and regulatory operations
Clinical-trial and regulatory-operations AI agents should be evaluated by the handoff they improve: accepted trial match, closed EDC query, inspection-ready eTMF document, clean registry/results update, usable endpoint record, safety-narrative QC or agency-response package.
AGENTSLife sciencesGLOBAL
2026-06-01
AI agents for pharmacovigilance and medical affairs
Pharmacovigilance and medical-affairs agents should preserve safety-to-label truth: AI-touched case facts, signal work items, label rationales, acceptor, downstream safety action and approved response boundary.
AGENTSLife sciencesGLOBAL
2026-06-01
AI models for real estate
Routes AI models for residential and commercial real estate across AVMs, source data, search, tenant access, brokerage, lease intelligence, CRE investment, AECO, climate risk, property computer vision, controls, vendor economics and cost per accepted property output.
MODELSReal estateGLOBAL
2026-05-31
AI agents for legal workflows
Legal AI agents should be bought as governed workflows: what they may read, draft, send, file, sign, remember, escalate and prove after lawyer review.
AGENTSLegal servicesGLOBAL
2026-05-31
AI agents for real estate
Real-estate AI agents should be routed by data right, action, fair-housing exposure, credit or valuation consequence, and human approval, with U.S. housing evidence treated as the densest current public risk signal and global vendor examples treated as workflow evidence.
AGENTSReal estateGLOBAL
2026-05-27